Ethiopia: MSF launches new healthcare programme in Oromia region

Source: Médecins Sans Frontières –

Médecins Sans Frontières (MSF) has launched a comprehensive general and specialist healthcare programme in the East Wollega and West Wollega zones of Ethiopia’s Oromia region.

We aim to restore access to essential services for host communities and internally displaced people in hard-to-reach rural areas, while strengthening the capacity of key health facilities.

In these rural zones, limited movement of patients, staff and supplies – along with shortages of medicines and medical equipment, financial barriers and weak referral systems – have made it harder to deliver timely, quality healthcare. Some facilities have operated at reduced capacity or faced temporary interruptions. 

As a result, communities have experienced untreated illness, challenges in sustaining immunisation and maternal health services, a high burden of malaria along with a greater risk of disease outbreaks, and increased pressure on the health facilities that remain functional. 
Despite the scale of need, the presence of humanitarian organisations in these zones remains limited, leaving significant gaps in both general and specialist care.

“The area has unmet health needs,” said Dr Sigrid Lamberg, MSF country director in Ethiopia. “Communities often lack routine care, while referral facilities have had little support to strengthen infection control, staff capacity and essential services.”

“The limited presence of international organisations in this area has created significant and growing gaps in essential health services,” says Dr Lamberg. “These gaps mean that people often delay seeking care or travel long distances when they become ill.”

In response, we started running mobile clinics that bring healthcare directly to areas with limited access in East Wollega and West Wollega. These mobile teams provide outpatient consultations, routine nutrition assessments, health promotion activities, and essential medicines with a strong aim to reduce preventable deaths. In West Wollega, MSF is providing targeted specialist-level support to Begi hospital, which serves a larger catchment of approximately 1 million people.

Our team focuses on strengthening infection prevention and control systems and building the capacity of health workers. This support is being rolled out in phases, beginning with the maternity department, with the aim of gradually reinforcing broader hospital functions. 

In July, the first month of operations, the mobile clinics provided outpatient care and essential services to 4,243 people; during the same period, at Begi hospital’s maternity department, our team supported 137 deliveries in collaboration with hospital staff.

By combining outreach with support to a key referral facility, our activities seek to create a more continuous and resilient pathway of care. Throughout the implementation of the programme, MSF has been working in close partnership with the Ministry of Health, local health authorities, and local communities.

“Communities in East Wollega and West Wollega have faced prolonged disruptions to basic health services,” said Dr Lamberg. “Our goal is to reinforce the capacity of selected facilities and outreach services so that quality care can be delivered closer to the communities who need it most.”

“It’s a collaborative approach to ensure that our support strengthens existing health structures rather than creating parallel systems,” they conclude.

Test of nature law standards is major curb on deforestation

Source: Greenpeace Statement –

SYDNEY, Thursday 20 August 2026 — Commenting on the release of the government’s final nature law standards made today, including for Matters of National Environmental Significance, the following lines can be attributed to Glenn Walker, Head of Nature at Greenpeace Australia Pacific: 

“Ultimately the test of the new nature law standards will be whether they materially bring down Australia’s shockingly high rates of deforestation caused by bulldozing for beef and logging of native forests.

“Deforestation severely threatens the forest homes of some of Australia’s most threatened species including the koala, greater glider and swift parrot. In Queensland the bulldozing of forests is causing mass erosion and the run off of hundreds of thousands of tonnes of muddy soil on the Great Barrier Reef each year.

“Unless these standards deliver protection for the Great Barrier Reef from deforestation runoff and ensure the healthy recovery of wildlife under threat then they will have failed. 

“There’s clear improvement on the draft standards that were released, which we welcome, but what we have today still falls well short of what would be optimal. In particular, the heavy reliance on offsets and the failure to address the cumulative impacts of hundreds of instances of deforestation–death by a thousand cuts–create serious ongoing weaknesses in the way the standards work. The acid test will now be in the operation: will the standards succeed in stopping deforestation, or not.

“The effectiveness of the nature law reforms hang heavily on these standards. We will be watching closely as they are implemented and raising the alarm on any failure to curb deforestation.”

-ENDS-

Italy: Disastrous offshore agreement with Albania must serve as a ‘wake-up call’ to end EU’s cruel migration plans

Source: Amnesty International –

The offshore detention of migrants and asylum seekers under the Italy-Albania Agreement is jeopardizing people’s safety, liberty and human rights, Amnesty International said in a briefing published as events in Ceuta continue to expose the dangers of long-standing European Union (EU) migration policies that centre on exclusion and containment.

Italy: Extraterritorial migration detention and human rights obligations analyzes the 2023 agreement to establish two migration facilities in Albania run by Italian authorities, which has led to the forcible transfer of hundreds of people who face being locked up, many unable to access legal help. The conditions there and harmful human costs of Italy’s offshore policies have driven several individuals to self-harm or attempt suicide.

“Offshore detention is ultimately aimed at deterrence and trying to shift and evade both the responsibilities of responding to people migrating and the obligation to provide asylum to those who need it. Italy’s deal with Albania shows yet again the unavoidable human rights costs of this approach,” said Eve Geddie, Director of Amnesty International’s European Institutions Office.  

“Just before the deal entered into force, Amnesty International sounded the alarm on the harmful impact it would inevitably have on the rights of people in distress at sea, and of people transferred to Albania. Clearly, these concerns have now materialized.”  

Amnesty International believe its findings must serve as a warning to the EU about the disastrous impact of migration policies that seek to increasingly rely on countries outside its borders to manage migration, at the expense of expanding safe and regular pathways.

Unnecessary cruelty

Between October 2024 and January 2025, Italy carried out three maritime operations and forcibly transferred 74 people directly from international waters to Albania under the Agreement. Following numerous Italian court rulings which overturned detention orders for these people, Italy stopped the transfers to Albania from the high seas.  

However, in March 2025, the Italian government amended the Agreement to allow for the detention in Albania of men with expulsion orders in Italy. As a result, hundreds (reportedly over 500) predominantly racialized men have been forcibly transferred to the Albanian detention centre in Gjadër over the past 15 months. 

Between 11 April and 16 May 2025, 42 critical incidents were recorded in the Gjadër centre, including at least two attempted hangings, a protest where three people were injured from shattered glass, and various self-harm incidents.

The Italian government has obstructed independent monitoring of the Agreement’s implementation, including by restricting parliamentary oversight and bypassing ordinary legislative processes. By limiting access and oversight by independent rights observers, what happens in the Albanian detention centres remains largely shrouded in secrecy. 

Whilst people detained in Albania fall under Italian jurisdiction, their physical distance from Italy combined with limited access to lawyers, courts and other safeguards, significantly undermines the effectiveness of the right to seek asylum and to access justice.

A lawyer interviewed by Amnesty International said he had been unable to meet his client before their hearing and had no time to adequately prepare the defence. In his view, the minutes of asylum hearings showing people answering questions in monosyllables was a sign they had been intimidated.

People detained in Albania are understandably traumatized.  What they are forced to undergo is an intolerable and unnecessary cruelty

Eve Geddie, Director of Amnesty International’s European Institutions Office

“People detained in Albania are understandably traumatized. They may have crossed the desert, been detained and abused in Libya, survived the sea crossing on unseaworthy boats, and then, following interception by the Italian authorities, spent days travelling to Albania. Others, transferred from detention in Italy, are ripped from their lives, leaving behind communities and support networks and are expected to suddenly contend with new surroundings, screenings, paperwork – all from a place of isolation. What they are forced to undergo is an intolerable and unnecessary cruelty,” said Eve Geddie.

Undermining the rule of law

Italian courts and the Court of Justice of the EU have found Italian rules and practice around asylum applications filed by people from countries designated by Italy as “safe” (the basis for fast tracking applications) to be inconsistent with the applicable EU law, and without sufficient safeguards for applicants.  

Despite repeated Italian court rulings ordering people’s release from detention in Albania, the Italian government has pushed ahead with implementing the deal. It has tried to limit courts’ scrutiny over the designation of “safe countries” by resorting to legislation intended for situations of urgency without providing reasons to undermine the rule of law.  

Individuals with expulsion orders in Italy and already in detention there, have also been subject to unlawful extraterritorial transfers, outside of provisions in domestic and European law.

“It is abundantly clear that the Italy-Albania model is impossible to implement in line with Italy’s human rights obligations. This reality must be a wake-up call for the EU to put any future plans to expand the use of offshore detention and other externalization tools, firmly on ice,” said Eve Geddie. 

“Italian authorities must immediately end the agreement with Albania, implement alternatives to migration detention, which under international law must remain the last resort, and ensure access to effective and non-discriminatory asylum procedures and dignified reception on Italian territory to all people seeking international protection. All refugees and migrants should be able to access effective legal safeguards and benefit from independent monitoring.” 

Background 

The Italy-Albania Agreement entered into force on 23 February 2024 and is set to remain in force for five years, after which time it will be automatically renewed. The Italian government is reported to have set side over €670 million for its operation until 2028.  

As the Italian Ministry of Interior repeatedly denied Amnesty International’s requests for access to the detention centres in Albania, citing security and public order reasons, the research is based on correspondence with the Ministry of Interior and a review of court documents, information exchanged within the Tavolo Asilo e Immigrazione civil society network, reports from parliamentarians and ombudspersons, interviews with UN agencies and with two lawyers of people detained in Gjadër.

Women risk their lives to reach healthcare in Port-au-Prince

Source: Médecins Sans Frontières –

In Port-au-Prince, Haiti, every movement poses a risk. For thousands of women, seeing a doctor, obtaining contraceptives, attending prenatal check-ups, or receiving care after sexual assault has become fraught with obstacles. 

In a capital where armed violence is undermining an already fragile health system, access to sexual and reproductive healthcare is increasingly limited. Yet such care remains essential at every stage of life. 

A collapsing health system  

One recent morning, a 29-year-old woman was admitted, barely conscious, to the Isaïe Jeanty Maternity hospital, which is supported by Médecins Sans Frontières (MSF). She had developed postpartum eclampsia – a serious complication that can be fatal without prompt treatment – after giving birth at home a few hours earlier. 

Her stepfather accompanied her on a motorcycle from Cité Soleil, a commune of Port-au-Prince, with her newborn baby in his arms. 

“I was shaking when I arrived; I thought it was a lost cause,” he says in the maternity ward, where about 15 women are being monitored by medical teams. “This morning, she looked as if she were dead. But now she’s almost smiling. It’s as if she had been brought back to life.”  

Haiti has the highest maternal mortality ratio in the Americas. The World Health Organization estimates that it stood at 328 deaths per 100,000 live births in 2023, compared to 197 globally and 58 in the Americas region. 

These numbers illustrate the gradual collapse of a health system weakened by the expansion of armed groups, institutional instability and chronic underfunding of public services. In Port-au-Prince, many health facilities have closed their doors, thus severely reducing access to essential healthcare — especially for women and their sexual and reproductive healthcare. 

Many pregnancies are not monitored by trained professionals, and births take place at home without medical assistance. Without timely access to healthcare, complications, such as eclampsia, haemorrhages, infections, or neonatal distress, may be detected too late. 

“We had to refer a woman at eight months of pregnancy to give birth to her baby who died in utero,” says a midwife at an MSF mobile clinic. “She had never been able to receive prenatal check-ups. This should not be happening. These are preventable complications that become fatal without medical support.”  

MSF staff see patients for sexual and reproductive health care consultations at a mobile clinic in Port-au-Prince, Haiti, December 2025.
Jelle Krings

Multiple obstacles to face 

For many women, reaching a health facility has become an ordeal. Armed clashes, shifting frontlines, checkpoints, roads blocked by mountains of rubbish, transport costs and forced displacement complicate every consultation. 

“Patient transfers are extremely difficult: transport is limited, and functional maternity and neonatal units are scarce,” says Naomi Lubin, an MSF supervising midwife. 

Added to this is another challenge: some women are reluctant to leave their neighbourhood for fear of being identified with their place of residence. In a city divided between neighbourhoods controlled by armed groups and others by the authorities, an address can be enough to stigmatise a person or lead others to suspect them of having links to an armed group. Leaving one’s neighbourhood to go to hospital can then become life-threatening. 

“My two-year-old child hasn’t been vaccinated for a year and a half because I can’t leave the area,” says a woman and MSF patient. “I don’t want to go out with my identity card with my address indicated. I’m scared. You could get killed.” 

Like many other women living in Port-au-Prince, violence is disrupting many aspects of her life, including access to healthcare.  

Maintaining healthcare despite the crisis 

In response, MSF has set up mobile activities to bring care closer to the communities. Every week, medical teams provide general healthcare in former schools or churches, in multiple neighbourhoods, offering consultations for several hours.  In the first half of 2026, they provided 4,500 sexual and reproductive health consultations. 

To strengthen the continuity of care in the long term, MSF is also investing in the rehabilitation of the Isaïe Jeanty Maternity hospital in Cité Soleil, an existing public facility. Working alongside the Ministry of Public Health and Population, the teams provide emergency obstetric care, including caesarean sections, as well as contraception and care for victims and survivors of sexual violence. 

In the first half of 2026, staff assisted with 929 deliveries, including 285 emergency caesarean sections. 257 patients were also referred, with their newborns, to other health facilities for the management of serious complications. 

Naomie Lubin, an MSF midwife at the Isaïe Jeanty Maternity hospital in Port-au-Prince, smiles while holding a newborn in her arms. Haiti, August 2026.
Marx Stanley Léveillé/MSF

Despite these efforts, people’s needs remain immense. Insecurity continues to limit the movement of patients and medical staff. 

“When clashes affect our medical facilities, we have to suspend our activities and evacuate the premises,” Diana Manilla Arroyo, MSF head of mission in Haiti.  “This has happened twice in the last two months. These suspensions drastically reduce referral options and complicate the management of obstetric emergencies, as well as many other sexual and reproductive health needs.” 

Ensuring continued access to this care remains essential to safeguarding the health and lives of thousands of women and girls in Port-au-Prince. 

Argentina: Unchecked deployment of AI-driven surveillance reinforces a techno-authoritarian infrastructure of social control 

Source: Amnesty International –

The expanded use of surveillance technologies in Argentina during the first two years of the Javier Milei’s administration has served to expand states surveillance capabilities, profiling and reprisals in the country, creating a chilling effect on rights to privacy and freedom of expression, peaceful assembly and association, Amnesty International said in a new report today. 

The report, Sensing the Surveillance State, documents how the government implemented sweeping institutional reforms to expand its intelligence capabilities and therefore surveillance mechanisms, through executive decrees and resolutions. Between 2024-2025, it also acquired technologies worth at least US$1.2 million, including social media monitoring tools, facial recognition, and aerial surveillance tools. Together, these policies and technologies amount to a system of mass surveillance. 

“Pervasive surveillance is being used against Argentinians in both physical and digital spaces, to devastating effect. These technologies have become an integral part of the infrastructure of state control, targeting dissent, deterring protest movements, and harassing marginalized groups, among other authoritarian practices,” said Paola Garcia Ray, Deputy Director, Amnesty International Argentina.

“When powerful people don’t want accountability, they attack those who ask questions and use whatever is at their disposal to monitor, control and repress.”  

The report is based on interviews with 21 people including journalists, activists, pensioners, young people and human rights defenders; analysis of scores of procurement documents and data related to acquired surveillance technologies; and information obtained through freedom of information (FOI) requests. 

Oxfam Reaction to the December European Council

Source: Oxfam –

Commenting at the close of the EU council meeting where leaders agreed on a new EU 2030 climate target and discussed the EU’s response to the Covid-19 pandemic, Evelien van Roemburg, head of Oxfam’s EU advocacy office said:  

Climate 

“The new, more ambitious, EU 2030 target still falls short of what is needed and what is fair. The EU must take urgent practical steps to deliver above and beyond this target.  

“It won’t be possible to deliver on the new climate target if governments don’t cut the emissions of the richest 10% of Europeans who are responsible for more than a quarter of EU emissions. We need a fair European Green Deal that tackles luxury carbon emissions and confronts inequality. This means ending subsidies for fossil fuels, introducing taxes on aviation fuel, and banning SUVs. Revenues should be invested in housing renovation and public transport that will deliver millions of jobs, clean air, and warm homes for everyone.” 

Covid-19 

“EU leaders’ talk of a ‘shared spirit of global solidarity to defeat the pandemic’ rings hollow given that they are actively blocking proposals at the World Trade Organisation that would force big pharma to waive their monopolies and patents on vaccines – a move that could boost vaccine production and end this pandemic faster. We need a People’s Vaccine, not a profit vaccine.” 
 

Oxfam safeguarding and culture improvement plan, April-Sept 2020

Source: Oxfam –

Oxfam reports every six months against its Safeguarding and Culture Improvement Plan. The latest report highlights Oxfam’s new Global Case Management System that allows for enhanced data analysis and oversight of safeguarding and other management compliances, along with improved mechanisms for reporting to donors and authorities. Oxfam is adapting its safeguarding guidance to teams to help them adjust to the realities of increased virtual working as a result of the coronavirus pandemic. This included participating in a confederation–wide real time evaluation into how we are supporting countries to respond to the coronavirus emergency, identifying and socializing best practises. The report includes Oxfam’s latest safeguarding disclosure data over the period covered, that shows the organization managed 88 safeguarding cases, closing out half of them including 21 as being upheld with appropriate actions taken. 
 

UNEP Emissions Gap Report – Reaction

Source: Oxfam –

Tim Gore, Head of Climate Policy at Oxfam, and a contributing author to the United Nations Environment Programme’s Emissions Gap Report 2020, said: 

“The UNEP report shows that the over-consumption of a wealthy minority is fuelling the climate crisis, yet it is poor communities and young people who are paying the price.

“It will be practically and politically impossible to close the emissions gap if governments don’t cut the carbon footprint of the wealthy and end the inequalities which leave millions of people without access to power or unable to heat their homes.

“A fair and green recovery will help the world bounce back from the from COVID-19 pandemic by creating millions of decent jobs, and help build more sustainable, resilient, economies that work for everyone.”

Tim Gore, a contributing author to Chapter 6 of the UNEP Emissions Gap Report 2020 – Bridging the Gap: the role of low carbon equitable lifestyles, is available for interview.

Oxfam’s report, Confronting Carbon Inequality, revealed that the richest one percent of the world’s population are responsible for more than twice as much carbon pollution as the 3.1 billion people who made up the poorest half of humanity during a critical 25-year period of unprecedented emissions growth. The report, which was released in September 2020, is based on research conducted with the Stockholm Environment Institute. Oxfam released new analysis on 8th December which showed that EU emissions cuts in the last 30 years were only achieved among poorer Europeans, while emissions of richest 10% have grown.

Anna Ratcliff, +447796993288 or anna.ratcliff@oxfam.org

For updates, please follow @Oxfam.

Campaigners warn that 9 out of 10 people in poor countries are set to miss out on COVID-19 vaccine next year

Source: Oxfam –

Nearly 70 poor countries will only be able to vaccinate one in ten people against COVID-19 next year unless urgent action is taken by governments and the pharmaceutical industry to make sure enough doses are produced, a group of campaigning organisations warned today. 

By contrast, wealthier nations have bought up enough doses to vaccinate their entire populations nearly three times over by the end of 2021 if those currently in clinical trials are all approved for use. Canada tops the chart with enough vaccines to vaccinate each Canadian five times. Updated data shows that rich nations representing just 14 per cent of the world’s population have bought up 53 per cent of all the most promising vaccines so far.

The organizations, including Amnesty International, Frontline AIDS, Global Justice Now and Oxfam, who are part of an alliance calling for a People’s Vaccine, used data collected by science information and analytics company Airfinity to analyze the deals done between countries and the eight leading vaccine candidates. They found that 67 low and lower middle-income countries risk being left behind as rich countries move towards their escape route from this pandemic. Five of the  67 – Kenya, Myanmar, Nigeria, Pakistan and Ukraine – have reported nearly 1.5 million cases between them.

Anna Marriott, Oxfam’s health policy Manager, said:  “No one should be blocked from getting a life-saving vaccine because of the country they live in or the amount of money in their pocket. But unless something changes dramatically, billions of people around the world will not receive a safe and effective vaccine for COVID-19 for years to come.” 

Heidi Chow, from Global Justice Now, said: “All pharmaceutical corporations and research institutions working on a vaccine must share the science, technological know-how, and intellectual property behind their vaccine so enough safe and effective doses can be produced. Governments must also ensure the pharmaceutical industry puts people’s lives before profits.”

The Pfizer/BioNTech vaccine has already received approval in the UK and vaccinations are beginning this week. It is likely to receive approval from other countries including the US within days. Two further potential vaccines, from Moderna and Oxford in partnership with AstraZeneca  are expected to submit or are awaiting regulatory approval. The Russian vaccine, Sputnik, has announced positive trial results and four other candidates are in phase 3 clinical trials.

So far, all of Moderna’s doses and 96 percent of Pfizer/BioNTech’s have been acquired by rich countries. In welcome contrast Oxford/AstraZeneca has pledged to provide 64 percent of their doses to people in developing nations. Yet despite their actions to scale up supply they can still only reach 18 per cent of the world’s population next year at most. Oxford/AstraZeneca deals have also mostly been made with some of the big developing countries like China and India, while the majority of developing countries have not done deals and have to share the COVAX pool of vaccines between them.

This demonstrates that one company alone cannot hope to supply the whole world, and that only open sharing of technology between vaccine producers can make this possible.

The People’s Vaccine Alliance is calling on all pharmaceutical corporations working on COVID-19 vaccines to openly share their technology and  intellectual property through the World Health Organization COVID-19 Technology Access Pool, so that billions more doses can be manufactured and safe and effective vaccines can be available to all who need them. 

The Alliance is also calling on governments to do everything in their power to ensure COVID-19 vaccines are made a global public good—free of charge to the public, fairly distributed and based on need. A first step would be to support South Africa and India’s proposal to the World Trade Organisation Council this week to waive intellectual property rights for COVID-19 vaccines, tests and treatments until everyone is protected.

Steve Cockburn, Amnesty International’s Head of Economic and Social Justice, said: “The hoarding of vaccines actively undermines global efforts to ensure that everyone, everywhere can be protected from COVID-19. Rich countries have clear human rights obligations not only to refrain from actions that could harm access to vaccines elsewhere, but also to cooperate and provide assistance to countries that need it.

“By buying up the vast majority of the world’s vaccine supply, rich countries are in breach of their human rights obligations. Instead, by working with others to share knowledge and scale up supply, they could help bring an end to the global COVID-19 crisis.”

The vaccines developed by AstraZeneca/Oxford, Moderna and Pfizer/BioNTech have received more than $5 billion dollars of public funding, which the alliance said placed a responsibility on them to act in the global public interest.

Dr. Mohga Kamal Yanni, from the People’s Vaccine Alliance, said: “Rich countries have enough doses to vaccinate everyone nearly three times over, whilst poor countries don’t have enough to even reach health workers and people at risk.

“The current system, where pharmaceutical corporations use government funding for research, retain exclusive rights and keep their technology secret to boost profits, could cost many lives.”

Lois Chingandu, Director of Frontline AIDS, said: “This pandemic is a global problem that requires a global solution. The global economy will continue to suffer so long as much of the world does not have access to a vaccine.

“We need to put pharmaceutical industry profit aside during this unprecedented pandemic, both to save humanity and the economy.”

Momentum is mounting for a People’s vaccine, which has already been backed by COVID survivors, health experts, activists, past and present world leaders, faith leaders and economists including: Cyril Ramaphosa, Imran Khan, Ellen Johnson Sirleaf, Gordon Brown, Helen Clark, Mary Robinson, Joseph Stiglitz, John Nkengasong and Thomas Piketty.

Last month in the US, more than 100 high-level leaders from public health, faith-based, racial justice, and labor organizations, joined former members of Congress, economists and artists to sign a public letter calling on President-elect Biden seize on this extraordinary moment and power of the US President to support a People’s Vaccine. 

Concurrently in the EU, a broad coalition of health worker trade unions, NGOs, activist groups, students associations and health experts launched a European Citizens’ Initiative for a people’s vaccine.  The Initiative would allow European citizens to introduce legislative proposals if they collect 1 million signatures.

All figures are based on the fact 2 doses are required apart from the Johnson & Johnson vaccine which is a single dose vaccine.

The People’s Vaccine Alliance is a coalition of global and national organizations and activists united under a common aim of campaigning for a ‘People’s Vaccine’. The call for a People’s Vaccine is backed by past and present world leaders, health experts, faith leaders and economists. For more information visit: https://peoplesvaccine.org

The figures have been calculated by analysing data from Airfinity for November 2020. The statistic ‘9 out of 10 people missing out on vaccines in 67 countries’ is based on the fact that 30 low-income countries and 37 lower-middle income countries currently will only have access to any vaccine through the COVAX Advanced Market Commitment (AMC). The 67 countries do not include middle-income countries such as Brazil, Indonesia and Vietnam, who have also made their own bilateral deals. So far, the COVAX AMC has managed to secure 700 million doses from the leading vaccine candidates, to be distributed between the 92 countries that have signed up.  The figure was reached by dividing 700 million doses by the population of the 92 countries (3.6 billion), then dividing that by two, as two doses are required by the vaccines already secured by COVAX AMC to vaccinate each individual. Details  of the COVAX AMC can be found here: https://www.gavi.org/news/media-room/92-low-middle-income-economies-eligible-access-covid-19-vaccines-gavi-covax-amc

The 67 countries are: Afghanistan, Angola, Algeria, Benin, Bhutan, Burundi, Burkina Faso, Cabo Verde, Cambodia, Cameroon, Central African Republic, Chad, Comoros, Republic of Congo (Brazzaville), Cote d’Ivoire, Democratic Republic of Congo, Djibouti, Eritrea, Ethiopia, Eswatini, Gambia, Ghana, The Guinea, Guinea-Bissau, Haiti, Kenya, Kiribati, Democratic People’s Republic of Korea, Kyrgyz Republic, Lao PDR, Lesotho, Liberia, Madagascar, Malawi, Mali, Mauritania, Micronesia, Moldova, Mongolia, Mozambique, Myanmar, Niger, Nigeria, Pakistan, Papua New Guinea, Rwanda, Sao Tome and Principe, Senegal, Sierra Leone, Solomon Islands, Somalia, South Sudan, Sri Lanka, Sudan, Syria, Tajikistan, Tanzania, Timor Leste, Togo, Tunisia, Uganda, Ukraine, Vanuatu, West Bank and Gaza, Yemen, Zambia, Zimbabwe.

Calculations of proportion of doses for rich and poor nations were based on analysing data on supply deals gathered by Airfinity. We examined the vaccine candidates that are in phase three trials that have done significant supply deals with countries across the world, cross-checking with original sources. There are currently eight of these: Astra Zeneca/Oxford, Novovax, Johnson & Johnson, Sanofi/GSK, Pfizer/BioNTech, Gamaleya/Sputnik, Moderna and Sinovac. 

According to data from Johns Hopkins, Kenya, Myanmar, Nigeria, Pakistan and Ukraine have had over 1.46m cases between them: https://coronavirus.jhu.edu/map.html

Breakdown of 8 leading vaccine candidates in Phase 3 that have done substantial deals with countries worldwide is available on request. 

Vaccine Candidate Distribution of doses b/w rich and poorer countries (by end 2021) Approx. Price Public money received Commitment to open sharing/ patents
Pfizer/ BioNTech

Total under contract: 1.128 billion doses

Rich countries:1.082 billion (96%)

Poorer  countries:
54 million (4%)

$19.50 a dose in US, two dose regimen. Represents up to 80% profit margin.  Yes- $546 million to BioNTech from EU and German govt.  $2 billion contract with US government.  BioNTech is the holder of the IP and neither BioNTech or Pfizer has made any commitment to sharing IP or joining the WHO C-TAP
Moderna

Total under contract: 777 million
Rich countries: 100%

Poorer countries: 0%

$12 to $32 a dose, two dose regimen. Considered to be ‘pandemic price only’  Yes- $2.48 billion from US government, if certain milestones are met. Yes, but limited. Will not enforce patents during the pandemic and willing to license IP post pandemic. No commitment to open sharing or WHO C-TAP.
Astra Zeneca/ Oxford

Total under contract: 2.731billion 

Rich countries:
983 million (36%)

Poorer countries:
1.747billion (64%)

$3-$5 a dose from the licensed Indian  Serum Institute  two dose regimen and no profit during pandemic. No profit to low income countries in perpetuity.

Yes – over $1.9 billion from US and UK governments, CEPI AND GAVI. IP owned by Oxford University. AZ has an exclusive license to develop and manufacture globally, including tech transfer, to contract manufacturing organisations and sublicencees but contracts are not transparent. 
AZ CEO openly opposed to any public sharing of technology and IP .
No commitment to open sharing or joining WHO C-TAP.
Novavax

Total under contract: 1.376 billion 

Rich countries:
376 million (27%)

Poorer countries
1 billion (73%)

$16 a dose $1.6 billion in US government funding Potential Tech transfer between Novavax and Indian Serum company  but not transparent. 
No commitment to open sharing of technology or IP or of joining WHO C-TAP.
Johnson and Johnson

Total under contract: 1.268 billion 

Rich countries:
768 million (61%) 

Poorer countries
500 million (39%)

$10 a dose, ‘non-profit’- one dose regimen $1.5 billion from US govt No commitment to open sharing of technology or IP or of joining WHO C-TAP
Sanofi/ GSK

Total under contract: 1.232 billion 

Rich countries:
1.032 billion doses (84%)

Poorer countries: 200 million doses
(16%)

$10.50 a dose ‘no-profit’ during pandemic. $2.1 billion from US govt  Loose commitment to ‘sharing their technology’ but no firm position on sharing IP and technology, and no commitment to joining WHO C-TAP
Sinovac

Total under contract: 229 million 

Rich countries (0%)

Developing  countries 
(100%)  

$13.50-$30 per dose Sinovac 40% owned by Chinese Govt. Also has benefited from loans from Chinese govt. Sinovac have shared technology with Indonesian and Brazilian producers but no commitment to WHO C-TAP. Xi Jinping has committed that all Chinese vaccines will be a ‘global public good’ 
Gamaleya/
Sputnik

Total under contract: 587 million
 
Rich countries (0.3%)

Poorer countries (99.7%)

$10 a dose Gamaleya institute that is developing the vaccine is publicly owned and operates under the Ministry of Health.  Some commitment to share technology according to some news reports but nothing concrete and no commitment to joining the WHO C-TAP. 

Russia: Anti-war politician Lev Shlosberg sentenced to 11 years and one month in prison amid mounting pressure on his Yabloko party

Source: Amnesty International –

Reacting to the sentencing of Lev Shlosberg, deputy chair of the Yabloko party — the only registered Russian political party which has consistently opposed Russia’s war of aggression against Ukraine and campaigned for a ceasefire and diplomacy — to 11 years and one month in prison, Marie Struthers, Amnesty International’s Eastern Europe and Central Asia Director, said:

“For nothing more than taking part in an anti-war debate and sharing a social media post, Lev Shlosberg faces more than 11 years behind bars. His arbitrary prosecution and sentencing are blatant reprisals for exercising his right to freedom of expression to call for peace.”

“The Yabloko party’s disqualification from running in the September State Duma election is further proof that political pluralism and anti-war expression have no place in Russia today.

“The Russian authorities must immediately and unconditionally release Lev Shlosberg and quash his conviction. They must repeal legislation criminalizing peaceful anti-war expression, end the persecution of Yabloko members and supporters, and respect the rights to freedom of expression, association, peaceful assembly and political participation for all Russians.”

In his final statement in the trial, Lev Shlosberg described how “thousands and thousands” of individuals have been targeted in Russia for their “peaceful, non-violent, and humanistic” beliefs. He concluded: “In reality, in this courtroom I am the Russian Federation, which has been put in a cage and which they want to force into silence.”

Background

On 17 August, the Pskov City Court sentenced Lev Shlosberg, a veteran Russian politician, journalist and deputy chair of Yabloko party, to 11 years and one month in a penal colony. He was prosecuted under Article 280.3(1) of the Russian Criminal Code for “repeated discreditation of the Russian Armed Forces,” and Article 207.3(2)(d) for “dissemination of deliberately false information about the Russian Armed Forces.” The charges relate to his participation in an online debate about the war against Ukraine and sharing on social media of a publication featuring a Daily Mirror front page showing Vladimir Putin and a blood-covered Ukrainian woman.

Lev Shlosberg’s trial ended amid mounting pressure on Yabloko. On 10 August 2026, Russia’s Supreme Court barred the party from running in the next State Duma election. Yabloko appealed the decision, and at least 30 of its supporters were detained outside the Supreme Court in Moscow on the day of appeal hearing on 17 August.